serw-MX  [xml]  
 


    
 DeCS Categories

G07 Physiological Phenomena .
G07.690 Pharmacological and Toxicological Phenomena .
G07.690.773 Pharmacological Phenomena .
G07.690.773.968 Drug Interactions .
G07.690.773.968.755 Herb-Drug Interactions .
K01 Humanities .
K01.752 Philosophy .
K01.752.566 Morals .
K01.752.566.479 Ethics .
K01.752.566.479.830 Principle-Based Ethics .
K01.752.566.479.830.500 Beneficence .
N03 Health Care Economics and Organizations .
N03.219 Economics .
N03.219.151 Costs and Cost Analysis .
N03.219.151.125 Cost-Benefit Analysis .
N03.219.521 Financing, Organized .
N03.219.521.576 Insurance .
N03.219.521.576.130 Insurance Benefits .
N03.219.521.576.343 Insurance, Health .
N03.219.521.576.343.575 Insurance, Pharmaceutical Services .
N05 Health Care Quality, Access, and Evaluation .
N05.350 Ethics .
N05.350.958 Principle-Based Ethics .
N05.350.958.500 Beneficence .
SP4 Environmental Health .
SP4.006 Environmental Engineering .
SP4.006.067 Environmental Economics .
SP4.006.067.548 Cost-Benefit Analysis .
SP4.051 General Aspects .
SP4.051.497 Costs and Cost Analysis .
SP4.051.497.018 Cost-Benefit Analysis .
SP8 Disasters .
SP8.473 Risk 17142 .
SP8.473.981 Disaster Vulnerability .
SP8.473.981.937 Socioeconomic Factors .
SP8.473.981.937.872 Cost-Benefit Analysis .
SP8.946 Disaster Management .
SP8.946.351 Impact of Disasters .
SP8.946.351.424 Damage Assessment Methodologies .
SP8.946.351.424.432 Cost-Benefit Analysis .
SP8.946.819 Prevention and Mitigation .
SP8.946.819.784 Cost-Benefit Analysis .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Insurance, Pharmaceutical Services .
Insurance, Pharmaceutic Services .
Insurance, Pharmacy Services .
Pharmaceutic Services Insurance .
Pharmaceutical Services Insurance .
Pharmacy Services Insurance .
Drug Benefit Plan .
Insurance, Drug .
Insurance, Prescription .
Plan, Drug Benefit .
Plans, Drug Benefit .
Drug Benefit Plans .
Drug Insurance .
Prescription Insurance .
Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products. .
1.00
 
Cost-Benefit Analysis .
Benefits and Costs .
Cost Benefit .
Cost Benefit Analysis .
Cost-Effectiveness Analysis .
Cost-Utility Analysis .
Costs and Benefits .
Economic Evaluation .
Marginal Analysis .
Analyses, Cost Benefit .
Analyses, Cost-Benefit .
Analyses, Cost-Utility .
Analyses, Marginal .
Analysis, Cost Benefit .
Analysis, Cost-Benefit .
Analysis, Cost-Effectiveness .
Analysis, Cost-Utility .
Analysis, Marginal .
Cost Benefit Analyses .
Cost Benefit Data .
Cost Effectiveness Analysis .
Cost Utility Analysis .
Cost-Benefit Analyses .
Cost-Utility Analyses .
Data, Cost-Benefit .
Economic Evaluations .
Effectiveness, Cost .
Evaluation, Economic .
Evaluations, Economic .
Marginal Analyses .
Cost Effectiveness .
Cost-Benefit Data .
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results. .
0.52
 
Insurance Benefits .
Insurance Beneficiary .
Beneficiaries, Insurance .
Beneficiary, Insurance .
Benefit, Health .
Benefit, Insurance .
Benefits, Health .
Benefits, Insurance .
Health Benefit .
Insurance Beneficiaries .
Insurance Benefit .
Health Benefits .
Payments or services provided under stated circumstances under the terms of an insurance policy. In prepayment programs, benefits are the services the programs will provide at defined locations and to the extent needed. .
0.51
 
Herb-Drug Interactions .
Drug-Herb Interactions .
Drug-Plant Interactions .
Herbal Drug Interactions .
Plant-Drug Interactions .
Drug Herb Interactions .
Drug Interaction, Herbal .
Drug Interactions, Herbal .
Drug Plant Interactions .
Drug-Herb Interaction .
Drug-Plant Interaction .
Herb Drug Interactions .
Herb-Drug Interaction .
Herbal Drug Interaction .
Interaction, Drug-Herb .
Interaction, Drug-Plant .
Interaction, Herb-Drug .
Interaction, Herbal Drug .
Interaction, Plant-Drug .
Interactions, Drug-Herb .
Interactions, Drug-Plant .
Interactions, Herb-Drug .
Interactions, Herbal Drug .
Interactions, Plant-Drug .
Plant Drug Interactions .
Plant-Drug Interaction .
The effect of herbs, other PLANTS, or PLANT EXTRACTS on the activity, metabolism, or toxicity of drugs. .
0.50
 
Beneficence .
Benevolence .
Nonmaleficence .
The state or quality of being kind, charitable, or beneficial. (from American Heritage Dictionary of the English Language, 4th ed). The ethical principle of BENEFICENCE requires producing net benefit over harm. (Bioethics Thesaurus) .
0.50